{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:21:55Z","timestamp":1770348115168,"version":"3.49.0"},"reference-count":52,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.3892\/or.2013.2546","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T07:55:14Z","timestamp":1371628514000},"page":"1337-1345","source":"Crossref","is-referenced-by-count":11,"title":["The insulin-like growth factor-1 and expression of its binding protein-3 in chronic hepatitis C and hepatocellular carcinoma"],"prefix":"10.3892","volume":"30","author":[{"given":"AGNIESZKA","family":"ADAMEK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALDONA","family":"KASPRZAK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HANNA","family":"MIKO\u0152","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WIES\u0141AWA","family":"PRZYBYSZEWSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AGNIESZKA","family":"SERASZEK-JAROS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ARKADIUSZ","family":"CZAJKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAROLINA","family":"STERZY\u0143SKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IWONA","family":"MOZER-LISEWSKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,6,19]]},"reference":[{"key":"key20180107223107_b1-or-30-03-1337","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180107223107_b2-or-30-03-1337","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"key20180107223107_b3-or-30-03-1337","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2007-1007116","article-title":"Hepatitis C virus and hepatocellular carcinoma","volume":"19","author":"Colombo","year":"1999","journal-title":"Semin Liver Dis"},{"key":"key20180107223107_b4-or-30-03-1337","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2893.2004.00521.x","article-title":"Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis","volume":"11","author":"Anzola","year":"2004","journal-title":"J Viral Hepat"},{"key":"key20180107223107_b5-or-30-03-1337","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1872-034X.2007.00261.x","article-title":"Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis","volume":"38","author":"Kasprzak","year":"2008","journal-title":"Hepatol Res"},{"key":"key20180107223107_b6-or-30-03-1337","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.bcp.2004.05.029","article-title":"An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocellular cells against drug-induced apoptosis","volume":"86","author":"Alexia","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"key20180107223107_b7-or-30-03-1337","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3892\/ijo.2012.1666","article-title":"The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)","volume":"41","author":"Kasprzak","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107223107_b8-or-30-03-1337","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin-like growth factors I and II: peptide, messenger ribonucleic acid, and gene structures, serum and tissue concentrations","volume":"10","author":"Daughday","year":"1989","journal-title":"Endocr Rev"},{"key":"key20180107223107_b9-or-30-03-1337","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0303-7207(94)90253-4","article-title":"Multiple levels of control of insulin-like growth factor gene expression","volume":"101","author":"Zarilli","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107223107_b10-or-30-03-1337","first-page":"744","article-title":"Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index","volume":"78","author":"Juul","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107223107_b11-or-30-03-1337","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11102-007-0035-9","article-title":"Normal levels of serum IGF-I: determinants and validity of current reference ranges","volume":"10","author":"Brabant","year":"2007","journal-title":"Pituitary"},{"key":"key20180107223107_b12-or-30-03-1337","first-page":"90","article-title":"Insulin-like growth factor binding proteins and their functions (minireview)","volume":"33","author":"Kostecka","year":"1999","journal-title":"Endocr Regul"},{"key":"key20180107223107_b13-or-30-03-1337","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001","volume":"22","author":"Le Roith","year":"2001","journal-title":"Endocr Rev"},{"key":"key20180107223107_b14-or-30-03-1337","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1515\/CCLM.2004.112","article-title":"Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3)","volume":"42","author":"Elmlinger","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"key20180107223107_b15-or-30-03-1337","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X","article-title":"Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation","volume":"13","author":"Yu","year":"1999","journal-title":"J Clin Lab Anal"},{"key":"key20180107223107_b16-or-30-03-1337","first-page":"2534","article-title":"Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation","volume":"80","author":"Juul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107223107_b17-or-30-03-1337","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ghir.2008.04.005","article-title":"Multidimensional reference region for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum healthy adults","volume":"18","author":"Mattsson","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"key20180107223107_b18-or-30-03-1337","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.trstmh.2010.01.012","article-title":"The potential role of insulin-like growth factor 1, insulin-like growth factor binding protein 3 and bone mineral density in patients with chronic hepatitis C virus in Cairo, Egypt","volume":"104","author":"Raslan","year":"2010","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key20180107223107_b19-or-30-03-1337","first-page":"1610","article-title":"Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion","volume":"76","author":"Blum","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107223107_b20-or-30-03-1337","first-page":"589","article-title":"Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia","volume":"112","author":"Wu","year":"1988","journal-title":"J Lab Clin Med"},{"key":"key20180107223107_b21-or-30-03-1337","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0029-1211366","article-title":"Regulation of growth hormone (GH), insulin-like growth factor (IGF) I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis","volume":"103","author":"Kratzsch","year":"1995","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key20180107223107_b22-or-30-03-1337","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-09-0374","article-title":"Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample","volume":"161","author":"V\u00f6lzke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key20180107223107_b23-or-30-03-1337","first-page":"949","article-title":"Serum IGF-1, IGF-2 and IGFBP-3 as a parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma","volume":"58","author":"Rehem","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"key20180107223107_b24-or-30-03-1337","first-page":"814","article-title":"Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis","volume":"50","author":"Vyzantiadis","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"key20180107223107_b25-or-30-03-1337","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1007\/s10620-006-9437-1","article-title":"Serum concentration of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C","volume":"52","author":"Lorenzo-Z\u00fa\u00f1iga","year":"2007","journal-title":"Dig Dis Sci"},{"key":"key20180107223107_b26-or-30-03-1337","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0009-8981(99)00254-5","article-title":"Serum insulin-like growth factor (IGF)-II is more closely associated with liver disfunction than is IGF-I in patients with cirrhosis","volume":"294","author":"Nikoli\u0107","year":"2000","journal-title":"Clin Chim Acta"},{"key":"key20180107223107_b27-or-30-03-1337","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/1097-0215(20000701)87:1<118::AID-IJC17>3.0.CO;2-W","article-title":"Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men","volume":"87","author":"Stuver","year":"2000","journal-title":"Int J Cancer"},{"key":"key20180107223107_b28-or-30-03-1337","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3748\/wjg.v10.i18.2740","article-title":"Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis","volume":"10","author":"Wu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"key20180107223107_b29-or-30-03-1337","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/cncr.11002","article-title":"Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study","volume":"95","author":"Mazziotti","year":"2002","journal-title":"Cancer"},{"key":"key20180107223107_b30-or-30-03-1337","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/003655200750056718","article-title":"Serum concentration of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis","volume":"35","author":"Okan","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"key20180107223107_b31-or-30-03-1337","first-page":"46","article-title":"Insulin growth-factor-1 and insulin-like growth factor binding protein-3 in Egyptian patients with chronic hepatitis C","volume":"3","author":"Raslan","year":"2007","journal-title":"Arch Med Sci"},{"key":"key20180107223107_b32-or-30-03-1337","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcla.20320","article-title":"Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study","volume":"24","author":"Su","year":"2010","journal-title":"J Clin Lab Anal"},{"key":"key20180107223107_b33-or-30-03-1337","first-page":"1511","article-title":"Hepatic production of insulin-like growth factors in normal and diseased liver","volume":"52","author":"Morali","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"key20180107223107_b34-or-30-03-1337","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.3748\/wjg.v12.i24.3821","article-title":"Increased hepatic expression of insulin-like growth factor-I receptor in chronic hepatitis C","volume":"28","author":"Stefano","year":"2006","journal-title":"World J Gastroenterol"},{"key":"key20180107223107_b35-or-30-03-1337","first-page":"115","article-title":"A possible role for insulin-like growth factor-binding protein-3 autocrine\/paracrine loops in controlling hepatocellular carcinoma cell proliferation","volume":"13","author":"Huynh","year":"2002","journal-title":"Cell Growth Differ"},{"key":"key20180107223107_b36-or-30-03-1337","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1359-6101(96)00053-6","article-title":"Insulin-like growth factor binding proteins and their role in controlling IGF actions","volume":"8","author":"Clemmons","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107223107_b37-or-30-03-1337","first-page":"263","article-title":"Expression of IGF-1 and viral proteins (C, NS3, NS5A) in the livers of patients with chronic HCV infection","volume":"20","author":"Kasprzak","year":"2011","journal-title":"Adv Clin Exp Med"},{"key":"key20180107223107_b38-or-30-03-1337","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"key20180107223107_b39-or-30-03-1337","first-page":"357","article-title":"Intracellular expression of the proliferative marker Ki-67 and viral proteins (NS3, NS5A and C) in chronic, long lasting hepatitis C virus (HCV) infection","volume":"45","author":"Kasprzak","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"key20180107223107_b40-or-30-03-1337","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"key20180107223107_b41-or-30-03-1337","first-page":"289","article-title":"From two to three-dimensional visualisation of structures in light and confocal microscopy - applications for biomedical studies","volume-title":"Current Issues on Multidisciplinary Microscopy Research and Education","author":"Kaczmarek","year":"2005"},{"key":"key20180107223107_b42-or-30-03-1337","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3748\/wjg.v13.i5.785","article-title":"Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases","volume":"13","author":"Mahdy","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20180107223107_b43-or-30-03-1337","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF03346389","article-title":"Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population","volume":"31","author":"Aimaretti","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"key20180107223107_b44-or-30-03-1337","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3109\/00365510903165477","article-title":"Characteristics and reference ranges of insulin-like growth factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians","volume":"69","author":"Andreassen","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"key20180107223107_b45-or-30-03-1337","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0004-27302010000500008","article-title":"Normal values of serum IGF-1 in adults: results from a Brazilian population","volume":"54","author":"Rosario","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"key20180107223107_b46-or-30-03-1337","first-page":"862","article-title":"Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations","volume":"11","author":"Holmes","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107223107_b47-or-30-03-1337","first-page":"245","article-title":"Serum insulin like growth factor-1 (IGF-1) and insulin growth factor binding protein-3 (IGFBP-3) levels in liver cirrhosis","volume":"18","author":"Colako\u0161lu","year":"2007","journal-title":"Turk J Gastroenterol"},{"key":"key20180107223107_b48-or-30-03-1337","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2007.01445.x","article-title":"Hepatitis-C patients have reduced growth hormone (GH) secretion which improves during long-term therapy with pegylated interferon-alpha","volume":"102","author":"Pl\u00f6ckinger","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key20180107223107_b49-or-30-03-1337","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12072-007-9007-4","article-title":"Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development on non-alcoholic fatty liver disease","volume":"1","author":"Ichikawa","year":"2007","journal-title":"Hepatol Int"},{"key":"key20180107223107_b50-or-30-03-1337","first-page":"1871","article-title":"Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver","volume":"79","author":"Arany","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107223107_b51-or-30-03-1337","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1677\/joe.0.1490209","article-title":"Expression of IGF-I and IGF-binding protein genes in cirrhotic liver","volume":"149","author":"Ross","year":"1996","journal-title":"J Endocrinol"},{"key":"key20180107223107_b52-or-30-03-1337","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2265.2003.01909.x","article-title":"Increased IGF-I:IGFBP-3 ratio in patients with hepatocellular carcinoma","volume":"59","author":"Mattera","year":"2003","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2546\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:40:39Z","timestamp":1515364839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,19]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,6,19]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.3892\/or.2013.2546"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2546","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,19]]}}}